NVIDIA Works With Deloitte to Deploy Digital AI Agents for Healthcare

Ahead of a visit to the hospital for a surgical procedure, patients often have plenty of questions about what to expect — and can be plenty nervous. To help minimize presurgery jitters, NVIDIA and Deloitte are developing AI agents using NVIDIA AI to bring the next generation of digital, frontline teammates to patients before they
Read Article

To Save Lives, and Energy, Wellcome Sanger Institute Speeds Cancer Research With NVIDIA Accelerated Computing

The Wellcome Sanger Institute, a key contributor to the international Human Genome Project, is turning to NVIDIA accelerated computing to save energy while saving lives. With one of the world’s largest sequencing facilities, the U.K.-based institute has read more than 48 petabases — or 48 quadrillion base pairs — of DNA and RNA sequences to
Read Article

Medical Centers Tap AI, Federated Learning for Better Cancer Detection

A committee of experts from top U.S. medical centers and research institutes is harnessing NVIDIA-powered federated learning to evaluate the impact of federated learning and AI-assisted annotation to train AI models for tumor segmentation. Federated learning is a technique for developing more accurate, generalizable AI models trained on data across diverse data sources without mitigating
Read Article

Climate Week Forecast: Outlook Improving With AI, Accelerated Computing

All the electricity that powers NVIDIA’s global operations will come from renewable sources by the end of January. It’s the right fuel for the company’s mission: to help customers and partners harness AI and accelerated computing for sustainable growth. This week, world leaders gather in New York City to mark Climate Week 2024. It’s a
Read Article

Better Molecules, Faster: NVIDIA NIM Agent Blueprint Redefines Hit Identification With Generative AI-Based Virtual Screening

Aiming at making the process faster and smarter, NVIDIA on Wednesday released the NIM Agent Blueprint for generative AI-based virtual screening. This innovative approach will reduce the time and cost of developing life-saving drugs, enabling quicker access to critical treatments for patients. This NIM Agent Blueprint introduces a paradigm shift in the drug discovery process,
Read Article